Overview

* USANA fiscal Q2 net sales grow 11% yr/yr, beating analyst expectations, per LSEG data

* Adjusted EPS for fiscal Q2 rises to $0.74, exceeding estimates, per LSEG data

* Company reiterates fiscal year 2025 outlook, despite decline in active customers

Outlook

* USANA reiterates fiscal 2025 net sales outlook of $920 mln to $1 bln

* Company expects fiscal 2025 adjusted EPS of $2.35 to $3.00

* USANA anticipates 8% to 17% sales growth in fiscal 2025

* Hiya sales expected to grow 29% to 42% in fiscal 2025

Result Drivers

* COMMERCIAL STRATEGY - USANA attributes 11% net sales growth to its comprehensive commercial strategy, including enhanced incentives and brand messaging

* HIYA PARTNERSHIP - Hiya's strong quarter driven by new partnership with Disney, boosting sales and subscriber growth

* CUSTOMER DECLINE - Active customer numbers fell across regions, impacting overall performance

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Sales Beat $235.85 $225.20

mln mln (1

Analyst)

Q2 Beat $0.74 $0.54 (1

Adjusted Analyst)

EPS

Analyst Coverage

* Wall Street's median 12-month price target for USANA Health Sciences Inc ( USNA ) is $61.00, about 50.3% above its July 21 closing price of $30.29

* The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 10 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)